Pre-Clinical Testing Issues Spark Questions From DES Manufacturers
This article was originally published in The Gray Sheet
Executive Summary
Manufacturers' comments and questions about FDA's proposed drug-eluting stent guidance are so far mainly focused on bench and animal testing issues, rather than clinical trials